Use of in vitro methaemoglobin generation to study antioxidant status in the diabetic erythrocyte

Biochemical Pharmacology

Volumn 60, Issue 10, 2000, Pages 1409-1416

  Coleman, Michael D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Antioxidants; Aromatic amines; Diabetic; Erythrocyte; GSH; Methaemoglobin; Nitrites

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUCOSE; GLUTATHIONE; HYDROXYLAMINE; METHEMOGLOBIN; NITRITE; THIOCTIC ACID; THIOL;

ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIET SUPPLEMENTATION; ERYTHROCYTE; ERYTHROCYTE LEVEL; EXPERIMENTAL MODEL; GLUTATHIONE METABOLISM; GLYCATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034670175     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00333-6     Document Type: Article

References (76)

1. Winterbourn C.C. Oxidative reactions of hemoglobin. Methods Enzymol. 186:1990;265-272.
2. Misra H.P., Fridovich I. The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem. 247:1972;6960-6962.
3. Mansouri A., Lurie A.A. Methemoglobinaemia. Am J Hematol. 42:1993;7-12.
4. Bunn H.F., Forget B.G. Hemoglobin oxidation Methemoglobin, methemoglobinemia and sulfhemoglobinemia . Bunn M.F., Forget B.G. Hemoglobin Molecular, Genetic and Clinical Aspects . 1986;635 W. B. Saunders, Philadelphia.
5. Coleman M.D., Coleman N.A. Drug-induced methaemoglobinaemia. Drug Saf. 14:1996;394-405.
6. Tursi F., Samaia M., Salmona M., Belvedere G. Styrene oxidation to styrene oxide in human erythrocytes catalyzed by oxyhemoglobin. Experientia. 39:1983;593-594.
7. Blisard K.S., Mieyal J.J. Characterization of the aniline hydroxylase activity of erythrocytes. J Biol Chem. 254:1979;5104-5110.
8. Kay M.M. Aging of cell membrane molecules leads to appearance of an aging antigen and removal of senescent cells. Gerontology. 31:1985;215-235.
9. Grossman S.J., Simson J., Jollow D.J. Dapsone-induced hemolytic anemia Effects of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes . Toxicol Appl Pharmacol. 117:1992;208-217.
10. Jakus V., Fuhr U., Worner W., Rietbrock N. Erythrocyte membrane fluidity in diabetics Fluorescence study . Collect Czech Chem Commun. 64:1999;548-552.
11. Linderkamp O., Ruef P., Zilow E.P., Hoffmann G.F. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia. 42:1999;865-869.
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
13. Bunn H.F., Higgins P.J. Reaction of monosaccharides with proteins Possible evolutionary significance . Science. 213:1981;222-224.
14. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
15. Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease Which role for oxidative stress? Metabolism. 44:1995;363-368.
16. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol. 44:1992;1905-1915.
17. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications A new perspective on an old paradigm . Diabetes. 48:1999;1-9.
18. Schmid-Schonbein H., Teitel P. In vitro assessment of `covertly abnormal' blood rheology; critical appraisal of presently available microrheological methodology. A review focusing on diabetic retinopathy as a possible consequence of rheological occlusion. Clin Hemorheol. 7:1987;203-238.
19. Wautier J.L., Wautier M.P., Anderson G.M., Hori O., Zoukourian C., Capron L., Chappey O., Yan S.D., Brett J., Guillausseau P.J., Stern D. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature A link between surface-associated AGEs and diabetic complications . Proc Natl Acad Sci USA. 91:1994;9441-9445.
20. Heikkela R., Cabatt F.S., Cohen G. In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J Biol Chem. 251:1976;2182-2185.
21. Ruiz C., Alegria A., Barbera R., Farre R., Lagarda M.J. Lipid peroxidation and antioxidant enzyme activities in patients with type I diabetes mellitus. Scand J Clin Lab Invest. 59:1999;99-105.
22. Adachi T., Ohta K., Hirano K., Hayashi K., Marklund S.L. Non-enzymatic glycation of human extracellular superoxide dismutase. Biochem J. 279:1991;263-267.
23. Saraswathi M., Nakanishi T., Shimizu A. Relative quantification of glycated Cu-Zn superoxide dismutase in erythrocytes by electrospray ionization mass spectrometry. Biochim Biophys Acta. 1426:1999;483-490.
24. Oda A., Bannai C., Yamaoka T., Katori T., Matsushima T., Yamashita K. Inactivation of Cu,Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm Metab Res. 26:1994;1-4.
25. Kotake M., Shinohara R., Kato K., Hayakawa N., Hayashi R., Uchimura K., Makino M., Nagata M., Kakizawa H., Nakagawa H., Nagasaka A., Itoh M. Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycemia in diabetic patients. Diabet Med. 15:1998;668-671.
26. Vijayalingam S., Parthiban A., Shanmugasunderam K.R., Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med. 13:1996;715-719.
27. Pereira B., Rosa L.F.B.P.C., Safi D.A., Bechara E.J.H., Curi R. Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophages. Biochem Pharmacol. 50:1995;2093-2098.
28. Muchova J., Liptakova A., Orszaghova Z., Garaiova I., Tison P., Carsky J., Durackova J. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus. Diabet Med. 16:1999;74-78.
29. Gupta B.L., Baquer N.Z. Hexokinase, glucose-6-phosphate dehydrogenase and antioxidant enzymes in diabetic reticulocytes Effects of insulin and vanadate . Biochem Mol Biol Int. 46:1998;1145-1152.
30. Zhang H., Agardh C.D., Agardh E. Retinal nitro blue tetrazolium staining and catalase activity in rat models of diabetes. Graefes Arch Clin Exp Ophthalmol. 234:1996;324-330.
31. Wang W., Ballatori N. Endogenous glutathione conjugates Occurrence and biological functions . Pharmacol Rev. 50:1998;335-354.
32. Coleman M.D., Jacobus D.P. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. Biochem Pharmacol. 45:1993;1027-1033.
33. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal Applications in research and therapy . Pharmacol Ther. 51:1991;155-194.
34. Jackson R.C. Studies in enzymology of glutathione metabolism in human erythrocytes. Biochem J. 111:1969;309-315.
35. Scott G.L., Rasbridge M.R. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells. Br J Haematol. 24:1973;307-317.
36. Costagliola C. Oxidative state of glutathione in red blood cells and plasma of diabetic patients In vivo and in vitro study . Clin Physiol Biochem. 8:1990;204-210.
37. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem. 52:1983;711-760.
38. Yoshida K., Hirokawa J., Tagami S.S., Kawakami Y., Urata Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus Regulation of glutathione synthesis and efflux . Diabetologia. 38:1995;201-210.
39. Dominguez C., Ruiz E., Gussinye M., Carrascosa C. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care. 21:1998;1736-1742.
40. Srivastava S.K., Ansari N.H., Liu S., Izban A. Das B, Szabo G and Bhatnagar A, The effect of oxidants on biomembranes and cellular metabolism. Mol Cell Biochem. 91:1989;149-157.
41. Di Simplicio P., de Georgio L.A., Cardaioli E., Lecis R., Miceli M., Rossi R., Anichini R., Mian M., Seghieri G., Franconi F. Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin-dependent diabetic patients Relation with platelet aggregation and microangiopatic complications . Eur J Clin Invest. 25:1995;665-669.
42. Ohtsuka Y., Yabunaka N., Watanabe I., Noro H., Agishi Y. Balneotherapy and platelet glutathione metabolism in type II diabetic patients. Int J Biometeorol. 39:1996;156-159.
43. Chen L.H., de Osio Y., Anderson J.W. Blood antioxidant defense system and dietary survey of elderly diabetic men. Arch Gerontol Geriatr. 28:1999;65-83.
44. Bolzan A.D., Bianchi M.S., Bianchi N.O. Superoxide dismutase, catalase and glutathione peroxidase activities in human blood Influence of sex, age and cigarette smoking . Clin Biochem. 30:1997;449-454.
45. Coleman M.D., Rustioni C.V. Resistance to GSH depletion in diabetic and non-diabetic human erythrocytes in vitro. J Pharm Pharmacol. 51:1999;23-27.
46. Murakami K., Kondo T., Ohtsuka Y., Fujiwara Y., Shimada M., Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism. 38:1989;753-758.
47. Bono A., Caimi G., Catania A. Red cell peroxide metabolism in diabetes mellitus. Horm Metab Res. 19:1987;264-266.
48. Blakytny R., Harding J.J. Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J. 288:1992;303-307.
49. Zhao W., Devamanoharan P.S., Varma S.D. Fructose induced deactivation of glucose-6-phosphate dehydrogenase activity and its prevention by pyruvate Implications in cataract prevention . Free Radic Res. 29:1998;315-320.
50. Bravi M.C., Pietrangeli P., Laurenti O., Basili S., Cassone-Faldetta M., Ferri C., De Mattia G. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism. 46:1997;1194-1198.
51. Srivastava S.K., Ansari N.H., Hair G.A., Jaspen J., Rao M.B. and Das B, Increased activity of aldose reductase in response to hyperglycaemia. Biochim Biophys Acta. 870:1986;302-311.
52. Kiese M. The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation. Pharmacol Rev. 18:1966;1091-1161.
53. Eyer P. Detoxication of N-oxygenated arylamines in erythrocytes. An overview. Xenobiotica. 18:1988;1327-1333.
54. Kramer P.A., Glader B.E., Li T.-K. Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4′-hydroxyaminodiphenylsulfone and other p-substituted derivatives. Biochem Pharmacol. 21:1972;1265-1274.
55. Coleman M.D., Hayes P.J., Jacobus D.P. Methaemoglobin formation due to nitrite, disulfiram, 4-aminophenol and monoacetyldapsone hydroxylamine in diabetic and non-diabetic human erythrocytes in vitro. Environ Toxicol Pharmacol. 5:1998;61-67.
56. Reilly T.P., Woster P.M., Svensson C.K. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone Implications for differences in adverse drug reactions . J Pharmacol Exp Ther. 288:1999;951-959.
57. Coleman M.D., Simpson J., Jacobus D.P. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III Effect of diabetes . Biochem Pharmacol. 48:1994;1341-1347.
58. Coleman M.D., Ogg M.S., Holmes J.L., Gardiner J.M., Jacobus D.P. Studies on the differential sensitivity between diabetic and non-diabetic human erythrocytes to monoacetyl dapsone hydroxylamine-mediated methaemoglobin formation in vitro. Environ Toxicol Pharmacol. 1:1996;97-102.
59. DeGowin R.L., Eppes R.B., Powell R.D., Carson P.E. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Org. 35:1966;165-179.
60. Eggleston L.V., Krebs H. Regulation of the pentose phosphate cycle. Biochem J. 138:1974;425-435.
61. Tomoda A., Tsuji A., Yoneyama Y. Involvement of superoxide anion in the reaction mechanism of haemoglobin oxidation by nitrite. Biochem J. 193:1981;169-179.
62. Kosaka H., Tyuma I. Mechanism of autocatalytic oxidation of oxyhemoglobin by nitrite. Environ Health Perspect. 73:1987;147-151.
63. Kosaka H., Uozumi M., Tyuma I. The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Radic Biol Med. 7:1989;653-658.
64. Tomoda A., Murakami E., Shibuya T. Production of nitric oxide (NO) during the oxidation of human oxyhemoglobin by nitrite Application of a NO-selective electrode for the measurement of NO . Artif Cells Blood Substit Immobil Biotechnol. 25:1997;501-509.
65. Lissi E. Autocatalytic oxidation of hemoglobin by nitrite A possible mechanism . Free Radic Biol Med. 24:1998;1535-1536.
66. Smith R.C., Gore J.Z., Doyle M.P. Degradation of uric acid during autocatalytic oxidation of oxyhemoglobin induced by sodium nitrite. Free Radic Biol Med. 11:1991;373-377.
67. Khalifah R.G., Baynes J.W., Hudson B.G. Amadorins Novel post-Amadori inhibitors of advanced glycation reactions . Biochem Biophys Res Commun. 257:1999;251-258.
68. Jain S.K., McVie R., Jaramillo J.J., Palmer M., Smith T. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients. J Am Coll Nutr. 15:1996;458-461.
69. Altenkirch H., Stoltenberg-Didinger G., Wagner H.M., Herrman J., Walter G. Effects of lipoic acid in hexacarbon-induced neuropathy. Neurotoxicol Teratol. 12:1990;619-622.
70. Cinaz P., Hasanoglu A., Bideci A., Biberoglu G. Plasma and erythrocyte vitamin E levels in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 12:1999;193-196.
71. Bast A., Haenen G.R.R.M. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta. 963:1988;558-561.
72. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 392:1998;559.
73. Ernst E., Matrai A. Altered red and white rheology in type II diabetes. Diabetes. 35:1986;1412-1415.
74. Coleman M.D., Breckenridge A.M., Park B.K. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Br J Clin Pharmacol. 28:1989;389-395.
75. Coleman M.D., Thorpe S., Lewis S., Buck N.S., Perris A.D., Seydel J.K. Preliminary evaluation of the toxicity and efficacy of novel 2,4-diamino-5-benzylpyrimidine-sulphone derivatives using rat and human tissues in vitro. Environ Toxicol Pharmacol. 2:1996;389-395.
76. Coleman M.D., Smith J.K., Buck N.S., Perris A.D., Seydel J.K. Studies on the anti-inflammatory effects of novel analogues of dapsone in vitro. J Pharm Pharmacol. 49:1997;53-57.